Cannabis: Difference between revisions
>ARGON Added "Vitamin deficiency" subsection to "Toxicity and harm potential" section, added references |
>Nathanfranke Revise citation for negative cognitive effects. Add paragraph for use during brain development, meta-analysis showing lasting changes in central executive and default mode networks, extent of risk is not entirely clear. |
||
Line 14: | Line 14: | ||
Cannabis is considered to have low to moderate abuse potential.{{citation needed}} Chronic use is associated with escalating tolerance and psychological dependence in some individuals.{{citation needed}} It has very low physical toxicity and is essentially impossible to physically overdose on. However, it is capable of exacerbating certain mental health symptoms like [[delusions]] or [[psychosis]] in predisposed individuals (see [[cannabis#toxicity and harm potential|this section]]).{{citation needed}} | Cannabis is considered to have low to moderate abuse potential.{{citation needed}} Chronic use is associated with escalating tolerance and psychological dependence in some individuals.{{citation needed}} It has very low physical toxicity and is essentially impossible to physically overdose on. However, it is capable of exacerbating certain mental health symptoms like [[delusions]] or [[psychosis]] in predisposed individuals (see [[cannabis#toxicity and harm potential|this section]]).{{citation needed}} | ||
Long-term cannabis | Long-term cannabis has been associated with negative cognitive effects such as brain fog, lowered motivation, difficulty learning, and inattention. These effects are typically reversible with tapered use and time off.<ref>Kevin Hill, MD, and MD Michael Hsu. “Cognitive Effects in Midlife of Long-Term Cannabis Use.” ''Harvard Health'', 14 June 2022, <nowiki>https://www.health.harvard.edu/blog/cognitive-effects-of-long-term-cannabis-use-in-midlife-202206142760</nowiki>.</ref> | ||
Cannabis use during brain development (including during pregnancy and adolescence) has been shown to interfere with a variety of neurobiological systems. Meta-analysis following ~5 weeks of abstinence shows lasting changes in the central executive and default mode networks, which are involved in attention and working memory. The extent of these changes as risk factors is not entirely clear.<ref>Hurd, Yasmin L., et al. “Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects.” ''Journal of Neuroscience'', Society for Neuroscience, 16 Oct. 2019, <nowiki>https://www.jneurosci.org/content/39/42/8250</nowiki>.</ref> | |||
It is highly advised to use [[harm reduction practices]] if using this substance. | It is highly advised to use [[harm reduction practices]] if using this substance. | ||
Line 175: | Line 177: | ||
Math to calculate the quantity needed weed: Desired THC from divided by the THC strength of the strain. For example, if you want to smoke 3 mg (a common dose) from cannabis with 12% THC: | Math to calculate the quantity needed weed: Desired THC from divided by the THC strength of the strain. For example, if you want to smoke 3 mg (a common dose) from cannabis with 12% THC: | ||
: 3 mg / 12% = 3/0.12 = 25 mg | |||
:3 mg / 12% = 3/0.12 = 25 mg | |||
==Strains and forms== | ==Strains and forms== | ||
Line 286: | Line 289: | ||
One study found that about 1 in 10 users of cannabis may develop dependence characterized by the occurrence of a withdrawal syndrome after abstinence. This withdrawal syndrome was found to peak 2-3 days after quitting and is mostly complete by 1 week; however, sleep disturbances and vivid dreams may persist for 2-3 weeks.<ref>{{cite journal | vauthors=((Winstock, A. R.)), ((Ford, C.)), ((Witton, J.)) | journal=BMJ | title=Assessment and management of cannabis use disorders in primary care | volume=340 | issue=apr01 1 | pages=c1571–c1571 | date=1 April 2010 | url=https://www.bmj.com/lookup/doi/10.1136/bmj.c1571 | issn=0959-8138 | doi=10.1136/bmj.c1571}}</ref> | One study found that about 1 in 10 users of cannabis may develop dependence characterized by the occurrence of a withdrawal syndrome after abstinence. This withdrawal syndrome was found to peak 2-3 days after quitting and is mostly complete by 1 week; however, sleep disturbances and vivid dreams may persist for 2-3 weeks.<ref>{{cite journal | vauthors=((Winstock, A. R.)), ((Ford, C.)), ((Witton, J.)) | journal=BMJ | title=Assessment and management of cannabis use disorders in primary care | volume=340 | issue=apr01 1 | pages=c1571–c1571 | date=1 April 2010 | url=https://www.bmj.com/lookup/doi/10.1136/bmj.c1571 | issn=0959-8138 | doi=10.1136/bmj.c1571}}</ref> | ||
===Dangerous interactions=== | ===Dangerous interactions=== |